Kezar Life Sciences
85 hedge funds and large institutions have $117M invested in Kezar Life Sciences in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
19% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 21
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.13% less ownership
Funds ownership: 5.2% → 5.07% (-0.13%)
Holders
85
Holding in Top 10
1
Calls
$403K
Puts
$286K
Top Buyers
| 1 | +$6.73M | |
| 2 | +$3.77M | |
| 3 | +$3.75M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$3.11M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3.11M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$6.82M | |
| 3 | -$4.71M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.63M |
| 5 |
CA
CHI Advisors
New York
|
-$611K |